Back
ESC2025 Premium Access

Thrombelastography identifies patients at risk for major adverse cardiovascular events after transcatheter aortic valve implantation

Session: Coexistence of coronary disease and aortic stenosis: challenges in percutaneous vs. surgical approach
Topic: Aortic Valve Intervention
Speaker: Doctor D. Hesselbarth (Freiburg, DE)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor David Hesselbarth

University Heart Center Freiburg-Bad Krozingen, Freiburg (Germany)
0 follower

3 more presentations in this session

The increase in non-coronary cusp calcification is associated with the risk of coronary artery occlusion during future transcatheter aortic valve in valve procedures

Speaker: Doctor K. Onishi (Osaka, JP)

Access
Abstract
Slides
Video
Like
Thumbnail

Assessment of commissural and coronary ostial alignment of aortic valve bioprosthesis after transcatheter aortic valve implantation

Speaker: Doctor H. Gamal (Cairo, EG)

Access
Abstract
Slides
Video
Like
Thumbnail

Comparative outcomes of transcatheter aortic valve replacement versus surgical aortic valve replacement in severe aortic stenosis: a systematic review and meta-analysis

Speaker: Doctor C. Ranasinghe (Birmingham, GB)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Coexistence of coronary disease and aortic stenosis: challenges in percutaneous vs. surgical approach

Speakers: Doctor D. Hesselbarth, Doctor K. Onishi, Doctor H. Gamal, Doctor C. Ranasinghe
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources